Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Drug Resistant Epilepsy × Anticonvulsants × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Epilepsy 2 Tuberous Sclerosis Complex-associated Refractory Seizures 1 Tuberous Sclerosis 1 Seizures 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Drug Resistant Epilepsy 1 Cognitive Dysfunction 1 Chronic Pain 1 Breast Neoplasms 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

perampanel 1 Sirolimus 1 Immunoglobulins, Intravenous 1 Cannabidiol 1 Anticonvulsants 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04650204 2023-06-22

Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy

Mayo Clinic

Phase 4 Terminated

4 enrolled 9 charts

Drug Resistant Epilepsy, Epilepsy, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡